Investors’ data
Latest news
- February 23, 2010
Thallion Announces 2009 Year End Results
- February 16, 2010
Thallion Pharmaceuticals and LFB biotechnologies Sign Definitive Agreement to Develop and Commercialize Treatment for E. Coli (STEC) Infection
- January 11, 2010
Thallion Announces Changes to Executive Management Structure and Board of Directors
Documentation
Corporate Governance
Thallion Pharmaceutical Inc. and its Board of Directors believe that transparent and sound corporate governance practices are critical to the Company’s long-term success.
The Board believes that the Company’s corporate governance practices are well aligned with the recommendations contained in the various applicable guidelines and regulations issued by the Toronto Stock Exchange (TSX Guidelines) and other securities regulators.
For further information, please refer to our corporate profile on SEDAR.